Opiant Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 11, 2021

Rhea-AI Summary

Opiant Pharmaceuticals (NASDAQ: OPNT) will report its third quarter 2021 financial results and pipeline updates on November 11, 2021, after U.S. market close. A conference call is scheduled for 4:30 p.m. ET on the same day to discuss the results and operational progress. Investors can access the call via phone or a live webcast through the company's website. Opiant is known for its development of NARCAN® Nasal Spray and is focusing on expanding its portfolio to address addictions and drug overdoses.

SANTA MONICA, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report third quarter 2021 financial results and pipeline updates on Thursday, November 11, 2021, after U.S. financial markets close. 

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Thursday, November 11, 2021 to discuss the results and operational progress.

To access the call, please dial 877-407-0792 in the U.S. or 201-689-8263 outside the U.S. and provide the conference ID number: 13723604. To access the live webcast, please visit http://public.viavid.com/index.php?id=146696. Following the live webcast, an archived version of the call will be available on the website.

Thursday November 11 @ 4:30 pm ET

Domestic:	877-407-0792
International:	201-689-8263
Conference ID:	13723604
Webcast:	http://public.viavid.com/index.php?id=146696

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN^® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com and follow Opiant on Twitter (@Opiant_Pharma).

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com

FAQ

When will Opiant Pharmaceuticals report its Q3 2021 financial results?

Opiant Pharmaceuticals will report its Q3 2021 financial results on November 11, 2021, after U.S. financial markets close.

What time is the Opiant Pharmaceuticals conference call scheduled?

The conference call is scheduled for November 11, 2021, at 4:30 p.m. ET.

How can I access the Opiant Pharmaceuticals earnings call?

You can access the earnings call by dialing 877-407-0792 in the U.S. or 201-689-8263 internationally, using the conference ID 13723604, or through the live webcast available on their website.

What is Opiant Pharmaceuticals known for?

Opiant Pharmaceuticals is known for developing NARCAN® Nasal Spray and aims to create new medicines to combat addictions and drug overdose.